# EnVision Endoscopy

> FDA-cleared SimpleStitch system for endoscopic tissue closure on standard flexible scopes.

## Why it is interesting

November 10, 2026 $11.5M Series A coincides with the first 50 patient procedures at pilot sites, following FDA clearance in 2025 and limited US market release in 2026; early case count is not proof of wide adoption or comparative clinical superiority.

## Profile

- **Latest funding:** Series A — $11.5M (November 10, 2026)
- **Latest known valuation:** Undisclosed (November 10, 2026)
- **Total disclosed equity funding:** $12M
- **Stage:** series-a
- **Status:** private
- **Industries:** N/A
- **Coverage:** full
- **Last updated:** 2026-11-11
- **Latest funding investors:** Puma Venture Capital, UTEC – University of Tokyo Edge Capital, Olympus Corporation of the Americas, MassVentures

## Key facts

- Nov 10, 2026 $11.5M oversubscribed Series A led by Puma Venture Capital; participation UTEC, Olympus Corporation of the Americas, MassVentures.
- SimpleStitch received FDA clearance in 2025 and entered a limited US market release in 2026.
- 50 completed patient procedures at pilot sites were reported, but no independent complication, comparative efficacy or broader utilization rates were disclosed.

## Funding history

- Series A · $11.5M · November 10, 2026
  Source: https://www.prnewswire.com/news-releases/envision-endoscopy-announces-oversubscribed-series-a-financing-and-reaches-first-50-patient-procedures-with-simplestitch-suturing-system-302934030.html

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** November 11, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/envision-endoscopy